AbbVie
In Chris Tsai's portfolio · Tsai Capital
Ticker ABBV
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Tsai Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2023 | Sell | 0 | |
| Q2 2023 | No change | 1,800 | 0.2% |
| Q1 2023 | Reduce 14% | 1,800 | 0.3% |
| Q4 2022 | Reduce 12% | 2,100 | 0.5% |
| Q3 2022 | No change | 2,400 | 0.4% |
| Q2 2022 | No change | 2,400 | 0.4% |
| Q1 2022 | Reduce 40% | 2,400 | 0.3% |
| Q4 2021 | No change | 4,000 | 0.4% |
| Q3 2021 | Reduce 9% | 4,000 | 0.4% |
| Q2 2021 | No change | 4,400 | 0.5% |
| Q1 2021 | No change | 4,400 | 0.5% |
| Q4 2020 | First 13F | 4,400 | 0.5% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.